Corbus Pharmaceuticals Stock (NASDAQ: CRBP) stock price, news, charts, stock research, profile.
Open | $33.330 |
Close | - |
Volume / Avg. | 446.000 / 965.765K |
Day Range | 33.330 - 33.330 |
52 Wk Range | 3.033 - 49.870 |
Market Cap | $351.992M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 5.62% |
Days to Cover | 1.96 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Corbus Pharmaceuticals (NASDAQ: CRBP) through any online brokerage.
Other companies in Corbus Pharmaceuticals’s space includes: Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), PepGen (NASDAQ:PEPG), Replimune Group (NASDAQ:REPL) and Anika Therapeutics (NASDAQ:ANIK).
The latest price target for Corbus Pharmaceuticals (NASDAQ: CRBP) was reported by Oppenheimer on Wednesday, March 13, 2024. The analyst firm set a price target for 58.00 expecting CRBP to rise to within 12 months (a possible 73.13% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Corbus Pharmaceuticals (NASDAQ: CRBP) is $33.5 last updated April 25, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Corbus Pharmaceuticals.
Corbus Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Corbus Pharmaceuticals.
Corbus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.